AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19179916 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded exercise intervention emphasizing stabilizing exercises
Number of subjects: 71
Study 19179916 — intervention group
Group type: COMPARATOR
Intervention: Daily walks
Number of subjects: 71
Study 17524208 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia patients in tasks 1 and 2
Number of subjects: 37
Study 17524208 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls in tasks 1 and 2
Number of subjects: 37
Study 17524208 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenia patients in task 3
Number of subjects: 37
Study 17524208 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls in task 3
Number of subjects: 37
Study 15712714 — intervention group
Group type: EXPERIMENTAL
Intervention: Reaction-board measurement method
Number of subjects: 0
Study 15712714 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental method
Number of subjects: 0
Study 11852293 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (10-20 microg/mL after 15 days of treatment)
Number of subjects: 10
Study 11852293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9826292 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror presence
Number of subjects: 43
Study 9826292 — intervention group
Group type: COMPARATOR
Intervention: No mirror
Number of subjects: 43
Study 7801180 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical diagnostic tests and procedures for spinal disorders
Number of subjects: 0
Study 7801180 — intervention group
Group type: EXPERIMENTAL
Intervention: Main study approaches in outcomes research
Number of subjects: 0
Study 31502676 — intervention group
Group type: EXPERIMENTAL
Intervention: Original method for generating null distributions of statistics pertaining to differences in G matrices
Number of subjects: 0
Study 31502676 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified method for generating null distributions of statistics pertaining to differences in G matrices
Number of subjects: 0
Study 31502676 — intervention group
Group type: EXPERIMENTAL
Intervention: Real data set analysis using both methods
Number of subjects: 0
Study 29229086 — intervention group
Group type: EXPERIMENTAL
Intervention: Ground-based walking training (supervised, 2-3 times per week for 8-10 weeks)
Number of subjects: 143
Study 29229086 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual medical care)
Number of subjects: 143
Study 26362226 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D supplementation (800 mg calcium and 400 IU vitamin D daily for 6 months)
Number of subjects: 17
Study 26362226 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 17
Study 23680679 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week, twice weekly exercise program
Number of subjects: 60
Study 23680679 — intervention group
Group type: COMPARATOR
Intervention: Usual-care control (CON) group
Number of subjects: 60
Study 21052731 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative education
Number of subjects: 96
Study 21052731 — intervention group
Group type: COMPARATOR
Intervention: Control condition (no preoperative education)
Number of subjects: 96
Study 17146375 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (15 sessions, 90 minutes each, divided into 3 modules: stress, coping, and adjustment; safer behaviors; and health behaviors)
Number of subjects: 936
Study 17146375 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention until trial completion)
Number of subjects: 936
Study 15854942 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative methylene blue administration (2 mg/kg intravenously for more than 30 minutes, starting 1 hour before surgery)
Number of subjects: 100
Study 12217418 — intervention group
Group type: EXPERIMENTAL
Intervention: Nociceptin (200pmol) administered into tender non-dominant trapezius muscles
Number of subjects: 14
Study 12217418 — intervention group
Group type: EXPERIMENTAL
Intervention: Nociceptin administered into temporal muscle (open labeled design)
Number of subjects: 14
Study 12217418 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group for the 10 subjects)
Number of subjects: 14
Study 10731128 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB phototherapy plus tazarotene
Number of subjects: 10
Study 10731128 — intervention group
Group type: COMPARATOR
Intervention: UVB phototherapy alone
Number of subjects: 10
Study 10731128 — intervention group
Group type: COMPARATOR
Intervention: UVB phototherapy plus vehicle gel
Number of subjects: 10
Study 8749244 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan 6 mg subcutaneously
Number of subjects: 138
Study 8749244 — intervention group
Group type: COMPARATOR
Intervention: Sumatriptan 12 mg subcutaneously
Number of subjects: 138
Study 2380574 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoreactivating light from BLB fluorescent lamps (UVA radiation)
Number of subjects: 8
Study 2380574 — intervention group
Group type: EXPERIMENTAL
Intervention: Photoreactivating light from incandescent bulbs (visible light)
Number of subjects: 8
Study 2380574 — intervention group
Group type: COMPARATOR
Intervention: UVB radiation exposure
Number of subjects: 8
Study 6779150 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide at a 20% concentration in an oil-in-water emulsion (Benoxyl 20)
Number of subjects: 0
Study 6779150 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 30871632 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behaviour Therapy (CBT)
Number of subjects: 0
Study 30871632 — intervention group
Group type: EXPERIMENTAL
Intervention: Graded Exercise Therapy (GET)
Number of subjects: 0
Study 30871632 — intervention group
Group type: COMPARATOR
Intervention: Adaptive Pacing Therapy (APT)
Number of subjects: 0
Study 30871632 — intervention group
Group type: COMPARATOR
Intervention: Specialized Medical Care
Number of subjects: 0
Study 28157140 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency department ventilator protocol targeting lung-protective tidal volume, positive end-expiratory pressure, oxygen weaning, and head-of-bed elevation.
Number of subjects: 229
Study 28157140 — intervention group
Group type: COMPARATOR
Intervention: Preintervention group (control)
Number of subjects: 229
Study 25704236 — intervention group
Group type: EXPERIMENTAL
Intervention: Loaded miniscrews
Number of subjects: 20
Study 25704236 — intervention group
Group type: EXPERIMENTAL
Intervention: Unloaded miniscrews
Number of subjects: 20
Study 23962535 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept (N=71)
Number of subjects: 115
Study 23962535 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N=34)
Number of subjects: 115
Study 21864830 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 64
Study 21864830 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinnitus Retraining Therapy (TRT)
Number of subjects: 64
Study 21864830 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 64
Study 19444560 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5 mg x kg(‐1) i.v. bolus 30 min before induction, followed by an infusion of 1.5 mg x kg(‐1) x h(‐1) until 1 h after surgery (n = 45)
Number of subjects: 90
Study 19444560 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (n = 45)
Number of subjects: 90
Study 17679315 — intervention group
Group type: EXPERIMENTAL
Intervention: Vagus nerve stimulation (VNS), details on dosage and duration not specified
Number of subjects: 0
Study 15020290 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-nucleotide polymorphisms (SNPs) in the IL1RN gene
Number of subjects: 0
Study 15020290 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequencing approach to the coding region of the IL1RN gene
Number of subjects: 0
Study 15020290 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype analysis of six SNPs
Number of subjects: 0
Study 12465163 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised aerobic exercise program
Number of subjects: 152
Study 12465163 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of supervised exercise program and group education
Number of subjects: 152
Study 12465163 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management education program
Number of subjects: 152
Study 12465163 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 152
Study 9690103 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention work sites
Number of subjects: 11237
Study 9690103 — intervention group
Group type: COMPARATOR
Intervention: Control work sites
Number of subjects: 11237
Study 8126497 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (total lymphoid irradiation, TLI)
Number of subjects: 27
Study 8126497 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 27
Study 8126497 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (TLI)
Number of subjects: 27
Study 2551008 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine i.v.
Number of subjects: 500
Study 2551008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 500
Study 1117404 — intervention group
Group type: EXPERIMENTAL
Intervention: High stress - common fate (both awaiting electric shock)
Number of subjects: 0
Study 1117404 — intervention group
Group type: COMPARATOR
Intervention: High stress - dissimilar fate (subject awaiting electric shock, confederate awaiting innocuous word association)
Number of subjects: 0
Study 1117404 — intervention group
Group type: COMPARATOR
Intervention: Low stress - dissimilar fate (subject awaiting word association, confederate awaiting shock)
Number of subjects: 0
Study 1117404 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stress - common fate (both awaiting innocuous word association)
Number of subjects: 0
Study 31895945 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker (CHW)‐led group‐based education and monitoring intervention, conducted fortnightly for 3 months.
Number of subjects: 637
Study 31895945 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 637
Study 31895945 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker (CHW)‐led group‐based education and monitoring intervention
Number of subjects: 637
Study 30657995 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRT (Multidisciplinary Intensive Rehabilitation Treatment)
Number of subjects: 60
Study 30657995 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRT-AT (MIRT with Aquatic Therapy)
Number of subjects: 60
Study 30657995 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRT
Number of subjects: 60
Study 30657995 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRT-AT
Number of subjects: 60
Study 29217004 — intervention group
Group type: EXPERIMENTAL
Intervention: Transapical (TA) TAVR
Number of subjects: 2084
Study 29217004 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral (TF) TAVR
Number of subjects: 2084
Study 26018633 — intervention group
Group type: EXPERIMENTAL
Intervention: Early invitation to food supplementation combined with multiple micronutrient supplements (MMS) including 30 mg iron and 400 μgm folic acid.
Number of subjects: 0
Study 26018633 — intervention group
Group type: COMPARATOR
Intervention: Usual invitation to food supplementation combined with 60 mg iron and 400 μgm folic acid (UFe60F).
Number of subjects: 0
Study 26018633 — intervention group
Group type: EXPERIMENTAL
Intervention: Incrementing UFe60F to EMMS.
Number of subjects: 0
Study 24334857 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous high‐molecular‐weight plasma protein fraction therapy (AHPT)
Number of subjects: 22
Study 24334857 — intervention group
Group type: COMPARATOR
Intervention: Autologous plasma therapy (APT)
Number of subjects: 22
Study 23102619 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation (75 mg/day for 12 weeks)
Number of subjects: 0
Study 23102619 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 17916183 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg/every other day)
Number of subjects: 36
Study 17916183 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 17888975 — intervention group
Group type: EXPERIMENTAL
Intervention: CorCap Cardiac Support Device
Number of subjects: 300
Study 15871025 — intervention group
Group type: EXPERIMENTAL
Intervention: Cataract surgery with foldable lens implantation
Number of subjects: 71
Study 11952923 — intervention group
Group type: EXPERIMENTAL
Intervention: Group musical therapy (15 sessions over 4 months)
Number of subjects: 66
Study 11952923 — intervention group
Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 66
Study 11952923 — intervention group
Group type: EXPERIMENTAL
Intervention: Group musical therapy
Number of subjects: 66
Study 10215959 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-induced immunodeficiency with hepatitis virus co-infection
Number of subjects: 6
Study 8583662 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (apr) 10(6) KIU infused immediately after anesthesia, before and after ECC, and during ECC (Group I)
Number of subjects: 14
Study 8583662 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (apr) 10(6) KIU infused before and at three hours after ECC, and 2 x 10(6) KIU immediately after ECC (Group II)
Number of subjects: 14
Study 8583662 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group II)
Number of subjects: 14
Study 2354476 — intervention group
Group type: EXPERIMENTAL
Intervention: Streptokinase
Number of subjects: 65
Study 2354476 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue type plasminogen activator
Number of subjects: 65
Study 2354476 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (no thrombolytic therapy)
Number of subjects: 65
Study 391176 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepartricin (SPA‐S‐160 enteric‐coated tablets)
Number of subjects: 20
Study 391176 — intervention group
Group type: COMPARATOR
Intervention: Clofibrate
Number of subjects: 20
Study 29215478 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 100
Study 29215478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 27258938 — intervention group
Group type: EXPERIMENTAL
Intervention: Eugluc‐Hiinsu clamp with GIP infusion (1.5 pmol/kg/min)
Number of subjects: 6
Study 27258938 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemic‐hyperinsulinemic clamp with GIP infusion (1.5 pmol/kg/min)
Number of subjects: 6
Study 27258938 — intervention group
Group type: COMPARATOR
Intervention: Hygluc‐Euinsu clamp
Number of subjects: 6
Study 25024629 — intervention group
Group type: EXPERIMENTAL
Intervention: I.31 high dose (n = 28)
Number of subjects: 84
Study 25024629 — intervention group
Group type: EXPERIMENTAL
Intervention: I.31 low dose (n = 27)
Number of subjects: 84
Study 25024629 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 29)
Number of subjects: 84
Study 25024629 — intervention group
Group type: EXPERIMENTAL
Intervention: I.31 high dose
Number of subjects: 84
Study 25024629 — intervention group
Group type: EXPERIMENTAL
Intervention: I.31 low dose
Number of subjects: 84
Study 25024629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 22050270 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-body fractional CO(2) laser therapy followed by NB‐UVB phototherapy
Number of subjects: 10
Study 22050270 — intervention group
Group type: COMPARATOR
Intervention: NB‐UVB alone
Number of subjects: 10
Study 20920436 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled FDKP (20 mg) in DNP subjects
Number of subjects: 69
Study 20920436 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled FDKP (20 mg) in subjects with normal renal function
Number of subjects: 69
Study 20920436 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled FDKP (20 mg) in healthy subjects
Number of subjects: 69
Study 20920436 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled FDKP (20 mg) in CLD subjects
Number of subjects: 69
Study 20920436 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous FDKP
Number of subjects: 69
Study 20920436 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral FDKP
Number of subjects: 69
Study 18576358 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocating Procedure Device (RPD)
Number of subjects: 566
Study 18576358 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety needle
Number of subjects: 566
Study 18576358 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciprocating Procedure Device (RPD) combined with safety needle
Number of subjects: 566
Study 18576358 — intervention group
Group type: COMPARATOR
Intervention: Conventional syringe
Number of subjects: 566
Study 15814861 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 256
Study 15814861 — intervention group
Group type: COMPARATOR
Intervention: Stretching Control
Number of subjects: 256
Study 12219858 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing the salience of social categorization at any level of the hierarchy (6 individuals, 2 subgroups, 1 collective)
Number of subjects: 0
Study 12219858 — intervention group
Group type: EXPERIMENTAL
Intervention: Individuating the members of the individuals' own subgroup and/or the opposing subgroup
Number of subjects: 0
Study 12219858 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-categorization with the opposing subgroup
Number of subjects: 0
Study 10505152 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser stapedotomy
Number of subjects: 34
Study 8751847 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioisotope stents (phosphorus-32)
Number of subjects: 0
Study 8751847 — intervention group
Group type: COMPARATOR
Intervention: Catheter-based radiation therapies
Number of subjects: 0
Study 1999372 — intervention group
Group type: EXPERIMENTAL
Intervention: Active therapy
Number of subjects: 4736
Study 1999372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4736
Study 6949928 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine irrigation
Number of subjects: 0
Study 6949928 — intervention group
Group type: COMPARATOR
Intervention: Placebo irrigation
Number of subjects: 0
Study 31337173 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoral nerve block I (PECS I) + Serratus-intercostal plane block (SPB)
Number of subjects: 61
Study 31337173 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia only (Control group)
Number of subjects: 61
Study 27704317 — intervention group
Group type: EXPERIMENTAL
Intervention: PVI + RSD
Number of subjects: 236
Study 27704317 — intervention group
Group type: COMPARATOR
Intervention: PVI alone
Number of subjects: 236
Study 27704317 — intervention group
Group type: COMPARATOR
Intervention: PVI (normal renal function)
Number of subjects: 236
Study 25786369 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 416 (10 mg)
Number of subjects: 100
Study 25786369 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 416 (5 mg)
Number of subjects: 100
Study 25786369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 24120932 — intervention group
Group type: EXPERIMENTAL
Intervention: High protein diet (3gkg(‐1)proteinBM(‐1)day(‐1))
Number of subjects: 8
Study 24120932 — intervention group
Group type: COMPARATOR
Intervention: Normal diet (1.5gkg(‐1)proteinBM(‐1)day(‐1))
Number of subjects: 8
Study 22054204 — intervention group
Group type: EXPERIMENTAL
Intervention: MEL 308 nm + oral vitamin E
Number of subjects: 53
Study 22054204 — intervention group
Group type: EXPERIMENTAL
Intervention: MEL 308 nm + 0.1% tacrolimus + oral vitamin E
Number of subjects: 53
Study 22054204 — intervention group
Group type: COMPARATOR
Intervention: Oral vitamin E
Number of subjects: 53
Study 19602250 — intervention group
Group type: EXPERIMENTAL
Intervention: Active acupuncture treatment (real acupuncture), 3 times per week for 12 sessions over 4 weeks.
Number of subjects: 0
Study 19602250 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture treatment, 3 times per week for 12 sessions over 4 weeks.
Number of subjects: 0
Study 19602250 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group, no treatment during the 4 weeks, only recording symptoms in a daily diary.
Number of subjects: 0
Study 17496402 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic lock therapy using vancomycin and gentamycin
Number of subjects: 63
Study 17496402 — intervention group
Group type: COMPARATOR
Intervention: Routine TCC management
Number of subjects: 63
Study 14691434 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic measures
Number of subjects: 100
Study 14691434 — intervention group
Group type: COMPARATOR
Intervention: Clinical predictor
Number of subjects: 100
Study 14691434 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic parameters
Number of subjects: 100
Study 11789646 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions in prehospital trauma care
Number of subjects: 6806
Study 11789646 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 6806
Study 11907931 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) - transdermal estradiol 50 micrograms/day and 5 mg medroxyprogesterone acetate (MPA) for 2 years
Number of subjects: 72
Study 11907931 — intervention group
Group type: COMPARATOR
Intervention: Non-users of HRT
Number of subjects: 72
Study 11907931 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercholesterolemic women
Number of subjects: 72
Study 11907931 — intervention group
Group type: COMPARATOR
Intervention: Normocholesterolemic women
Number of subjects: 72
Study 7815242 — intervention group
Group type: EXPERIMENTAL
Intervention: High dosing (1,500 U lipase/kg body weight/meal, 750 U lipase/kg body weight/snack)
Number of subjects: 21
Study 7815242 — intervention group
Group type: COMPARATOR
Intervention: Standard dosing (500 U lipase/kg body weight/meal, 250 U lipase/kg body weight/snack)
Number of subjects: 21
Study 7815242 — intervention group
Group type: EXPERIMENTAL
Intervention: High dosing in Group 1 (n = 7)
Number of subjects: 21
Study 7815242 — intervention group
Group type: EXPERIMENTAL
Intervention: High dosing in Group 2 (n = 14)
Number of subjects: 21
Study 2900252 — intervention group
Group type: EXPERIMENTAL
Intervention: Bethanechol (5.0 mg s.c.)
Number of subjects: 0